Search results for "Cardiovascular Disease"
ACC releases expert consensus decision pathway on tobacco cessation treatment
The decision pathway provides a structured approach to evaluating and treating tobacco dependence and offers practical guidance for overcoming challenges commonly encountered in the clinical setting.
https://immattersacp.org/weekly/archives/2018/12/11/1.htm
11 Dec 2018
New assessment tool may improve predictions of CV risk, impact of preventive treatments
The new three-step tool aims to provide a framework for delivering appropriate risk-reducing strategies to Medicare patients with a 10-year atherosclerotic cardiovascular disease risk greater than 30%.
https://immattersacp.org/weekly/archives/2016/11/08/4.htm
8 Nov 2016
NAFLD treatment starts with weight loss, then other modes
Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016
Analyses from SPRINT examine cost-effectiveness, patient-reported outcomes with intensive BP control
The first analysis used a microsimulation model to apply findings from SPRINT to a hypothetical cohort of eligible patients. The second compared patient-reported outcomes from SPRINT in the intensive versus the standard treatment group.
https://immattersacp.org/weekly/archives/2017/08/29/2.htm
29 Aug 2017
Intensive blood pressure lowering may not induce true kidney disease
The findings can help improve understanding of the significance of creatinine elevations observed during hypertension therapy.
https://immattersacp.org/weekly/archives/2018/10/23/1.htm
23 Oct 2018
Pearls for lowering lipids
New guidelines recommend basing treatment decisions on levels of risk rather than LDL targets.
https://immattersacp.org/archives/2016/07/lipids.htm
1 Jul 2016
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/22/1.htm
22 Nov 2016
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/15/1.htm
15 Nov 2016
Focused cardiac ultrasonography's diagnostic potential limited by low specificity
Clinicians should understand the appropriate clinical use of focused cardiac ultrasonography, given its inherent limitations in both image acquisition and interpretation, and when formal echocardiography should be obtained, said the authors of a new study.
https://immattersacp.org/weekly/archives/2019/08/06/1.htm
6 Aug 2019
Label change for pioglitazone-containing medications
This column reviews a label change for medicine that contain pioglitazone and a new indication for empagliflozin.
https://immattersacp.org/archives/2017/02/fda.htm
1 Feb 2017